Newsroom
Top Results
Retreatment With A Single TearCare™ Treatment Continues To Provide Relief For Patients With Dry Eye Disease
A new, single center, prospective clinical study published in the January issue of Clinical Ophthalmology provides preliminary evidence that retreatment with the Sight Sciences TearCare System is a safe and effective treatment for dry eye disease, according to a company news release. The TearCare System is indicated for use in meibomian gland dysfunction (MGD), dry eye, and […]
Sight Sciences Announces Official Launches of TearCare™ and the Enhanced, Next Generation OMNI™ System
New Dry Eye and MIGS Entrants will be Prominently Featured in Product Demonstrations and Events at Upcoming Industry Shows MENLO PARK, Calif. – Sight Sciences, Inc., a growth-stage medical device company transforming the two fastest growing segments in ophthalmology and optometry – dry eye and glaucoma – today announced the official commercial launch of TearCare™ […]